AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
CLONAZEPAM
20 registrations across 6 African markets— 17 active
Markets with CLONAZEPAM
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| REMIALZ 0,5 mg TABLETS | 🇿🇦South Africa | Pharmacare Limited û Woodmead | active | Oct 2028 |
| REMIALZ 2 mg TABLETS | 🇿🇦South Africa | Pharmacare Limited û Woodmead | active | Oct 2028 |
| PMS CLONAZEPAM Comprimé sécable / 2 mg | 🇹🇳Tunisia | PHARMASCIENCE INC CANADA | expired | Apr 2009 |
| PMS CLONAZEPAM Comprimé sécable / 2 mg | 🇹🇳Tunisia | PHARMASCIENCE INC CANADA | expired | Mar 2005 |
| AKLONIL Comprimé sécable / 2 MG | 🇹🇳Tunisia | MEDOCHEMIE LTD | expired | May 1993 |
| RIVOTRIL 2 mg TABLETS | 🇿🇦South Africa | Pharmaco Distribution (Pty) Ltd | active | Jan 1900 |
| RIVOTRIL 2,5 mg/ml DROPS | 🇿🇦South Africa | Roche Products (Pty) Ltd | active | Jan 1900 |
| RIVOTRIL 0,5 mg | 🇿🇦South Africa | Pharmaco Distribution (Pty) Ltd | active | Jan 1900 |
| CLONAZEPAM 0,5 ASCENDIS | 🇿🇦South Africa | Ascendis Pharma (Pty) Ltd | active | Jan 1900 |
| RIVOTRIL 1 mg/ml AMPOULES | 🇿🇦South Africa | Pharmaco Distribution (Pty) Ltd | active | Jan 1900 |
| CLONAZEPAM 2 ASCENDIS | 🇿🇦South Africa | Ascendis Pharma (Pty) Ltd | active | Jan 1900 |
| CLONAZEPAM ORAL SOLID
ORDINARY
TABLETS | 🇺🇬Uganda | LINCOLN PHARMACEUTICA LS LTD. | active | — |
| PHARMATRIL comprimé / 2 mg | 🇸🇳Senegal | PHARMACO DISTRIBUTION LTD | active | — |
| KLONOPIN COMPRIME QUADRISECABLE | 🇲🇦Morocco | — | active | — |
| CLONAZEPAM ORAL SOLID
ORDINARY TABLETS | 🇺🇬Uganda | LINCOLN PHARMACEUTICA LS LTD. | active | — |
| CLONAZEPAM ORAL SOLID
ORDINARY TABLETS | 🇺🇬Uganda | LINCOLN PHARMACEUTICA LS LTD. | active | — |
| Clonotril 0.5 Tablets | 🇹🇿Tanzania | Remedica LTD | active | — |
| CLONAZEPAM ORAL SOLID
ORDINARY
TABLETS | 🇺🇬Uganda | LINCOLN PHARMACEUTICA LS LTD. | active | — |
| Coclam Oral tablet | 🇹🇿Tanzania | Centaur Pharmaceuticals Pvt. Ltd | active | — |
| Clonotril Tablets | 🇹🇿Tanzania | Remedica LTD | active | — |
CLONAZEPAM in Africa — Regulatory Overview
CLONAZEPAM is registered across 6 African markets with 20 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Uganda, Tunisia, Tanzania and 2 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 20 registrations, 17 (85%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.